 | Up a level |
2021
von Hardenberg, Jost 
ORCID: 0000-0002-0728-681X, Cash, Hannes ORCID: 0000-0002-1064-5633, Koch, Daniel, Borkowetz, Angelika, Bruendl, Johannes, Leyh-Bannurah, Sami-Ramzi, Kuru, Timur H., Kowalewski, Karl-Friedrich ORCID: 0000-0003-2931-6247, Schindele, Daniel, Mala, Katharina S., Westhoff, Niklas, Blana, Andreas and Schostak, Martin
(2021).
Triggers and oncologic outcome of salvage radical prostatectomy, salvage radiotherapy and active surveillance after focal therapy of prostate cancer.
World J. Urol., 39 (10).
S. 3747 - 3755.
NEW YORK:
SPRINGER.
ISSN 1433-8726
2020
Kempf, Emmanuelle, Penel, Nicolas, Tournigand, Christophe, Gajate, Pablo, Tan, Daniel Shao-Weng, Cassier, Philippe, Nogova, Lucia, Cathomas, Richard, Schostak, Martin, Janitzky, Andreas, Wermke, Martin, Sayehli, Cyrus, Navarro, Alejandro, Park, Se Hoon, Piciu, Ana-Maria, Bender, Sebastian, Nogai, Hendrik, Ellinghaus, Peter, Joerger, Markus and Schuler, Martin H. (2020). Phase I experience with rogaratinib in patients (pts) with urothelial carcinoma (UC) selected based on FGFR mRNA overexpression. J. Clin. Oncol., 38 (6). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
2019
Schuler, Martin, Cho, Byoung Chuf, Sayehli, Cyrus Michael, Navarro, Alejandro, Soo, Ross A., Richly, Heike, Cassier, Philippe Alexandre, Tai, David, Penel, Nicolas, Nagoya, Lucia, Park, Se Hoon, Schostak, Martin, Gajate, Pablo, Cathomas, Richard, Rajagopalan, Prabhu, Grevel, Joachim ORCID: 0000-0002-4635-7211, Bender, Sebastian, Boix, Oliver, Nogai, Hendrik, Ocker, Matthias ORCID: 0000-0001-8263-6288, Eflinghaus, Peter and Joerger, Markus
(2019).
Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study.
Lancet Oncol., 20 (10).
S. 1454 - 1467.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-5488
2018
Ganzer, Roman, Hadaschik, Boris ORCID: 0000-0002-1052-2692, Pahernik, Sascha, Koch, Daniel, Baumunk, Daniel, Kuru, Timur, Heidenreich, Axel, Stolzenburg, Jens-Uwe, Schostak, Martin and Blana, Andreas
(2018).
Prospective Multicenter Phase II Study on Focal Therapy (Hemiablation) of the Prostate with High Intensity Focused Ultrasound.
J. Urol., 199 (4).
S. 983 - 989.
PHILADELPHIA:
LIPPINCOTT WILLIAMS & WILKINS.
ISSN 1527-3792
Joerger, Markus, Cassier, Philippe, Penel, Nicolas, Cathomas, Richard, Richly, Heike, Schostak, Martin, Janitzky, Andreas, Wermke, Martin, Nogova, Lucia, Tai, David Wai-Meng, Sayehli, Cyrus, Gruellich, Carsten, Grande, Enrique, Navarro, Alejandra, Park, Se Hoon, Gillessen, Silke, Nogai, Hendrik, Bender, Sebastian, Ellinghaus, Peter and Schuler, Martin H. (2018). Rogaratinib treatment of patients with advanced urothelial carcinomas prescreened for tumor FGFR mRNA expression. J. Clin. Oncol., 36 (6). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Joerger, Markus, Cassier, Philippe Alexandre, Penel, Nicolas, Cathomas, Richard, Richly, Heike, Schostak, Martin, Janitzky, Andreas, Wermke, Martin, Nogova, Lucia, Tai, David Wai-Meng, Sayehli, Cyrus, Grullich, Carsten, Grande, Enrique, Navarro, Alejandro, Park, Se Hoon, Nogai, Hendrik, Bender, Sebastian, Ellinghaus, Peter and Schuler, Martin H. (2018). Rogaratinib in patients with advanced urothelial carcinomas prescreened for tumor FGFR mRNA expression and effects of mutations in the FGFR signaling pathway. J. Clin. Oncol., 36 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755